NCT03703297 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 264
- group Id
- BG001
- value
- 200
- group Id
- BG002
- value
- 266
- group Id
- BG003
- value
- 730
- units
- Participants
- groups
- description
- Participants received durvalumab monotherapy (1500 mg for participants \>30 kg in weight and a weight-based dosing equivalent to 20 mg/kg for participants \<=30 kg in weight) via IV infusion once q4w, until clinical/RECIST 1.1-defined radiological progression, intolerable toxicity, or for a maximum of 24 months, whichever occurred first.
- id
- BG000
- title
- Durvalumab
- description
- Participants received durvalumab in combination with tremelimumab (1500 mg durvalumab in combination with 75 mg tremelimumab for participants \>30 kg in weight and a weight-based dosing equivalent to 20 mg/kg durvalumab in combination with 1 mg/kg tremelimumab for participants \<=30 kg in weight) via IV infusion once q4w, until clinical/RECIST 1.1-defined radiological progression, intolerable toxicity, or for a maximum of 24 months, whichever occurred first.
- id
- BG001
- title
- Durvalumab Plus Tremelimumab
- description
- Participants received matching placebo via IV infusion once q4w for 4 doses/cycles each, until clinical/RECIST 1.1-defined radiological progression, intolerable toxicity, or for a maximum of 24 months, whichever occurred first.
- id
- BG002
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 160
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 162
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- <65 years
- measurements
- group Id
- BG000
- value
- 104
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 104
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 86
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 78
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Female
- measurements
- group Id
- BG000
- value
- 178
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 188
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 130
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 137
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 3
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 131
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 121
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Asian
- measurements
- group Id
- BG000
- value
- 2
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 5
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 14
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 255
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 249
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 3
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The full analysis set (FAS) included all randomized participants.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 264
- group Id
- BG001
- value
- 200
- group Id
- BG002
- value
- 266
- group Id
- BG003
- value
- 730
- units
- Participants
- groups
- description
- Participants received durvalumab monotherapy (1500 mg for participants \>30 kg in weight and a weight-based dosing equivalent to 20 mg/kg for participants \<=30 kg in weight) via IV infusion once q4w, until clinical/RECIST 1.1-defined radiological progression, intolerable toxicity, or for a maximum of 24 months, whichever occurred first.
- id
- BG000
- title
- Durvalumab
- description
- Participants received durvalumab in combination with tremelimumab (1500 mg durvalumab in combination with 75 mg tremelimumab for participants \>30 kg in weight and a weight-based dosing equivalent to 20 mg/kg durvalumab in combination with 1 mg/kg tremelimumab for participants \<=30 kg in weight) via IV infusion once q4w, until clinical/RECIST 1.1-defined radiological progression, intolerable toxicity, or for a maximum of 24 months, whichever occurred first.
- id
- BG001
- title
- Durvalumab Plus Tremelimumab
- description
- Participants received matching placebo via IV infusion once q4w for 4 doses/cycles each, until clinical/RECIST 1.1-defined radiological progression, intolerable toxicity, or for a maximum of 24 months, whichever occurred first.
- id
- BG002
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 160
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 162
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- <65 years
- measurements
- group Id
- BG000
- value
- 104
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 104
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 86
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 78
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Female
- measurements
- group Id
- BG000
- value
- 178
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 188
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 130
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 137
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- White
- measurements
- group Id
- BG000
- value
- 1
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 3
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 131
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 121
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Asian
- measurements
- group Id
- BG000
- value
- 2
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 5
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 14
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 255
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 249
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- comment
- Based on the results of the secondary objectives at the interim analysis (reviewed by an unblinded IDMC), data for the D+T arm were to remain blinded to the Sponsor as pre-specified in the study's unblinding plan. Since the D+T arm was blinded at the time of posting the results from this interim analysis, results for that arm will be posted at the time of final analysis.
- group Id
- BG001
- value
- NA
- group Id
- BG002
- value
- 3
- comment
- Total not calculated because data are not available (NA) in one or more arms.
- group Id
- BG003
- value
- NA
- title
- Missing
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- The full analysis set (FAS) included all randomized participants.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle